data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Zai Lab
(NASDAQ:ZLAB)
$41.41
2.87[7.45%]
At close: Jul 5
$42.00
0.5900[1.42%]
After Hours: 7:17PM EDT
Day High/Low38.21 - 42.74
52 Week High/Low22.51 - 178.91
Open / Close38.21 / 41.41
Float / Outstanding- / 97.9M
Vol / Avg.1.4M / 625.3K
Mkt Cap4.1B
P/E-
50d Avg. Price32.55
Div / Yield-
Payout Ratio-
EPS-0.9
Total Float-

Zai Lab (NASDAQ:ZLAB), Quotes and News Summary

Zai Lab (NASDAQ: ZLAB)

Day High/Low38.21 - 42.74
52 Week High/Low22.51 - 178.91
Open / Close38.21 / 41.41
Float / Outstanding- / 97.9M
Vol / Avg.1.4M / 625.3K
Mkt Cap4.1B
P/E-
50d Avg. Price32.55
Div / Yield-
Payout Ratio-
EPS-0.9
Total Float-
Benzinga - Jun 21, 2022, 4:44AM
Benzinga - Jun 10, 2022, 7:31AM
Benzinga - Jun 7, 2022, 1:08PM
Benzinga - Jun 3, 2022, 1:06PM
Benzinga - Jun 3, 2022, 8:01AM
Benzinga - May 12, 2022, 12:46PM
Benzinga - May 12, 2022, 7:37AM
Benzinga - May 11, 2022, 11:20AM
Benzinga - May 11, 2022, 8:49AM
Benzinga - May 10, 2022, 4:24PM
Benzinga - May 5, 2022, 11:56AM
Benzinga - Apr 28, 2022, 7:35AM
Benzinga - Apr 26, 2022, 2:01PM
Benzinga - Apr 21, 2022, 11:15AM
Benzinga - Apr 11, 2022, 11:34AM
Benzinga - Apr 6, 2022, 8:03AM
Benzinga - Apr 4, 2022, 10:14AM
Benzinga - Mar 28, 2022, 12:12PM
Benzinga - Mar 28, 2022, 12:11PM
Benzinga - Mar 21, 2022, 9:54AM
Sector: Health Care.Industry: Biotechnology
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC. The other product candidate includes Fugan, ZL-2302, and ZL-1101.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-1.200-0.860 0.3400
REV45.720M46.724M1.004M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Zai Lab Questions & Answers

Q
How do I buy Zai Lab (ZLAB) stock?
A

You can purchase shares of Zai Lab (NASDAQ: ZLAB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Zai Lab's (ZLAB) competitors?
Q
What is the target price for Zai Lab (ZLAB) stock?
A

The latest price target for Zai Lab (NASDAQ: ZLAB) was reported by Citigroup on Thursday, May 12, 2022. The analyst firm set a price target for 193.00 expecting ZLAB to rise to within 12 months (a possible 366.07% upside). 9 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Zai Lab (ZLAB)?
A

The stock price for Zai Lab (NASDAQ: ZLAB) is $41.41 last updated July 5, 2022, 8:00 PM UTC.

Q
Does Zai Lab (ZLAB) pay a dividend?
A

There are no upcoming dividends for Zai Lab.

Q
When is Zai Lab (NASDAQ:ZLAB) reporting earnings?
A

Zai Lab’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Zai Lab (ZLAB) going to split?
A

There is no upcoming split for Zai Lab.

Q
What sector and industry does Zai Lab (ZLAB) operate in?
A

Zai Lab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.